LLY

792.2

+2.51%↑

UNH

602.01

+1.14%↑

JNJ

157.14

-0.69%↓

NVO

106.9

+0.64%↑

ABBV

201.25

-0.66%↓

LLY

792.2

+2.51%↑

UNH

602.01

+1.14%↑

JNJ

157.14

-0.69%↓

NVO

106.9

+0.64%↑

ABBV

201.25

-0.66%↓

LLY

792.2

+2.51%↑

UNH

602.01

+1.14%↑

JNJ

157.14

-0.69%↓

NVO

106.9

+0.64%↑

ABBV

201.25

-0.66%↓

LLY

792.2

+2.51%↑

UNH

602.01

+1.14%↑

JNJ

157.14

-0.69%↓

NVO

106.9

+0.64%↑

ABBV

201.25

-0.66%↓

LLY

792.2

+2.51%↑

UNH

602.01

+1.14%↑

JNJ

157.14

-0.69%↓

NVO

106.9

+0.64%↑

ABBV

201.25

-0.66%↓

Search

Baxter International Inc

Closed

Sector Healthcare

36.12 0.31

Overview

Share price change

24h

Current

Min

35.68

Max

36.76

Key metrics

By Trading Economics

Income

-351M

-314M

Sales

3.8B

3.8B

EPS

0.68

Profit margin

-8.241

Employees

60,000

EBITDA

-419M

135M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+11.63 upside

Dividends

By Dow Jones

Next Earnings

8 Nov 2024

Next Ex Dividend date

27 Nov 2024

Market Stats

By TradingEconomics

Market Cap

-79M

18B

Previous open

35.81

Previous close

36.12

News Sentiment

By Acuity

17%

83%

36 / 390 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Baxter International Inc Chart

Past performance is not a reliable indicator of future results.

Related News

27 Mar 2024, 21:59 UTC

Acquisitions, Mergers, Takeovers

3M's Healthcare Spinoff Stock Fell. This Is What It's Worth. -- Barrons.com

27 Mar 2024, 09:15 UTC

Acquisitions, Mergers, Takeovers

3M's Healthcare Spinoff Stock Is Trading. This Is What It's Worth. -- Barrons.com

Peer Comparison

Price change

Baxter International Inc Forecast

Price Target

By TipRanks

11.63% upside

12 Months Forecast

Average 40.3 USD  11.63%

High 46 USD

Low 30 USD

Based on 10 Wall Street analysts offering 12 month price targets forBaxter International Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

10 ratings

1

Buy

8

Hold

1

Sell

Technical Score

By Trading Central

35.8408 / 36.2301Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

36 / 390 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Baxter International Inc

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.